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In people with uncontrolled chronic epilepsy there is an excess mortality directly attributable to the epilepsy itself. 
This is largely due to accidental and non-accidental deaths occurring during or immediately after seizures. Most 
sudden unexpected deaths in epilepsy fall within the latter category. To acknowledge rather than conceal these 
deaths is essential before prevention strategies can be addressed. 
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One hundred years ago the potential for an 
epileptic seizure to end life was acknowledged. 
Epileptologists in the nineteenth and early 
twentieth century described mortality in patients 
with epilepsy attributable to the epilepsy itselflg. 
With the advent of effective modern antiepileptic 
drugs (AEDs), the setting altered. Patients with 
epilepsy had moved out of asylums into the 
community and there was less opportunity for 
direct observation. In an attempt to limit restric- 
tions, risks from epilepsy were minimized then 
denied; that seizures could not be fatal became 
‘common knowledge’. The pendulum swung too 
far. Epilepsy came to be regarded as benign with 
consequences of seizures underplayed. 
That there is an observed overall excess 
mortality in populations with epilepsy of two to 
three times that of the general population is not 
disputed, though this has been largely attributed 
to mortality from underlying disease6. This is true 
for patients with recent onset epilepsy. It does 
not, however, explain the observed excess mor- 
tality in patients with chronic epilepsy’,‘. The 
residual excess, once deaths from underlying 
disease are excluded, is of relatively small 
magnitude in unselected community-based 
cohorts’,“. Such cohorts are appropriately con- 
sidered the gold standard in epidemiological 
research in understanding the natural history of 
epilepsy. However, given the high remission rates 
of epilepsy in community based cohorts”*‘*, one 
must question the relevance of mortality data 
from such studies to patients with long-standing 
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active epilepsy. Mortality rates in the latter are 
higher and in young adults more than half the 
deaths are epilepsy related. In two recent studies 
of patients with chronic largely uncontrolled 
epilepsy, age- and sex-standardized mortality 
ratios of 5.1r3 and 15.914 were observed, with 58% 
and 71% of deaths, respectively, classified as 
epilepsy related. The second cohort was one of 
young people with epilepsy and learning 
difficulty. 
In people with epilepsy, deaths may be related 
to underlying disease or to the epilepsy, or may 
be unrelated. The distinction is not always clear in 
individual cases (e.g. suicides, accidents, respira- 
tory deaths). An associated excess, where pre- 
sent, may be demonstrated by comparing the 
observed incidence of a particular cause of death 
in a cohort to that in the general population. 
Epilepsy-related deaths may be either 
treatment- or seizure-related. The latter include 
those in status epilepticus (in the absence of an 
acute neurological insult where it is the underly- 
ing condition rather than status per se that mainly 
determines mortality15) and deaths in the setting 
of a single seizure. The second category, hitherto 
relatively neglected, deserves further discussion. 
Classification is not without difficulty. Causes of 
death include trauma or drowning secondary to a 
seizure. Death may also occur during a habitual 
seizure in the presence of significant unrelated 
pathology, such as ischaemic heart disease. The 
magnitude of such deaths, where there is sig- 
nificant co-existing unrelated pathology, and the 
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relative contribution of the epilepsy to the 
person’s demise is unknown. This area warrants 
further study in view of the observed second peak 
in incidence of epilepsy among the elderly and its 
association with vascular disease. Deaths may 
also occur from severe aspiration during a seizure 
or from obstruction due to a food bolus and in 
such cases post-mortem examination reveals the 
cause of death. There remains however a 
category of deaths where persons with epilepsy 
may die suddenly and ‘unexpectedly in the ab- 
sence of an anatomical or toxicological cause16-*’ 
(SUDEP). While post-mortem examination is 
often abnormal with findings of oedema of 
organs, particularly lungs28, bronchial secretions 
or minor aspiration, these are not deemed 
sufficient to cause death. Although occasionally 
witnessed, the majority of these deaths are 
unwitnessed, making it difficult to be certain that 
they occurred during or shortly after a seizure. 
Where it is sought, circumstantial or physical 
evidence in favour of a seizure is often foundz9 
supporting the view that most cases falling within 
this category are seizure-related. In some, the 
body is found face down or the head in such a 
position that suffocation during postictal insen- 
sibility may have contributed to death. In such 
cases both intrinsic and extrinsic mechanisms are 
likely to contribute, and classifying individual 
deaths into either an extrinsic or intrinsic 
category is not usually possible. In many cases 
however, probably the majority, there is no 
obvious extrinsic impediment to respiration. 
Mechanisms are not well understood but are 
probably multifactorial. Ictal and postictal car- 
diorespiratory disturbances are likely to be 
involved in SUDEP cases. Both bradycardia and 
apnoea, central and/or obstructive, have been 
reported during seizures, with bradycardia more 
likely to occur in the presence of apnoea3’. 
Hypoxia may be aggravated by pulmonary 
oedema, bronchial secretions and any external 
obstruction to breathing. It is worth again noting 
that the majority of these deaths are nocturnal 
and unwitnessed raising the possibility that 
unwitnessed seizures are more likely to be fatal. 
While there may be more than one explanation 
for this observation, its possible implication to 
prevention needs to be assessed. 
Incidence data on sudden death is broadly 
consistent with the type of cohort. A community 
study, based on AED prescribing, observed an 
incidence of SUDEP of approximately 
1: lOOO/yea?‘. A study based on identified deaths 
in a defined community and estimated prevalence 
of epilepsy reported an incidence of 1 :65332. 
Selected populations however have a higher risk. 
Reports range from 1: 50-100/yea?1*33 among 
patients in an epilepsy surgery programme, 
1:260/year among long-term residents34, 
1:200/year in two specialist outpatient 
cohorts’3*‘7, 1:295/year in a cohort of young 
people with epilepsy and learning difficulty14, and 
1:500/year from a further outpatient unit3’. 
These high incidence rates contrast sharply with 
only two such deaths among patients in remission 
in over 5000 patient years reported by the MRC 
AED Withdrawal Study Group3’, and no cases in 
3712 person years relating to 564 newly- 
diagnosed definite cases in the National General 
Practice Study of Epilepsy’“. The latter is a study 
of incident cases with an increased early mortality 
from underlying disease and high remission rates 
in the remainder. Thus, controlled patients, 
whether as a result of treatment or inherently less 
severe disease, have an extremely low risk of 
sudden death. Cohorts with uncontrolled epilepsy 
carry a significant risk. This view is supported by a 
recent finding of higher risk related to number of 
AEDs ever prescribed, a likely surrogate for poor 
contro131. 
Such sudden unexpected deaths make up 
between 0” and 50%14 of causes of death in 
cohorts with epilepsy, although the more usual 
limits quoted are 7-17%37. Those aged 15-35 
have the highest risk, but data on other age- 
groups is limited. Studies have addressed mor- 
tality in the elderly with epilepsf8 and cardiac 
deaths in populations with epilepsf9. There are 
difficulties, however, in separating SUDEP 
deaths from those due to heart disease. Sudden 
deaths also occur in children40,41 although the 
incidence is probably lower. Whether this reflects 
better supervision or differences in seizure 
severity or both is uncertain. Literature from the 
U.S.A. highlights Afro-American non-compliant 
young men who abuse alcohol as particularly at 
risk23. Such patients are not necessarily represen- 
tative. Most studies report a higher male in- 
cidence. A history of tonic-clonic seizures is 
usually obtained4*. It has been suggested that 
sudden deaths are more likely in remote sympto- 
matic epilepsy, but this may reflect more severe 
epilepsy. The same may apply for the increased 
risk reported with psychotropic drug 
prescriptions3’. SUDEP also occurs in primary 
generalized-epilepsy and in people with relatively 
few seizures, but as already stated, it is a rare 
event in remission. 
On current evidence, there is no reason to 
implicate a particular AED in the majority of 
cases. Differences in reported medication appear 
Sudden unexpected deaths in epilepsy-where are we now? 
to reflect changes over time in prescribing 
practice. It has been suggested, on the basis of 
post-mortem AED levels, that withdrawal/non- 
compliance may be a precipitating factor43*““. The 
reliability of post-mortem samples has been 
questionned4’ and the significance of absolute 
values of drug levels, once overdose is excluded, 
is uncertain. Nevertheless, the potential contribu- 
tion of improved control in reducing risk of 
sudden death, and the dangers inherent in 
noncompliance and precipitous drug withdrawal 
cannot be dismissed. The significance of excessive 
alcohol, sleep deprivation or medication with- 
drawal probably lies in their potential to precipit- 
ate seizures. There is also the theoretical pos- 
sibility that they may, in addition, predispose to 
autonomic instability thus increasing the risk of 
death in a seizure. 
There is no uniformity in death certification of 
SUDEP cases, although, given that over 90% of 
identified cases in our experience in the U.K.46 
are referred to the coroner and undergo post- 
mortem examination, uniformity is possible and 
must be sought. Status epilepticus, though unsub- 
stantiated, is often recorded as a cause of death, 
although our impression is that this is less likely to 
be the case now than previously. Unfortunately, 
with the situation as it stands and until there are 
agreements regarding definitions and guidelines 
for certification of epilepsy related deaths, and for 
the methods by which data is subsequently 
incorporated into national mortality figures, the 
exact numbers involved remain unknown. It is 
estimated that 400 individuals with epilepsy per 
year die a sudden unexpected death. This figure 
excludes other epilepsy-related deaths. A work- 
shop, curently being planned, addressing these 
issues as well as directions for future research is 
long overdue. 
Nevertheless, while much remains to be done, 
there has been increased awareness of epilepsy- 
related deaths including sudden unexpected 
deaths over the last few years. Much of the 
impetus has come from the self-help group 
Epilepsy Bereaved?47, and through its efforts 
some of the understandable reluctance of all 
concerned to address the small but definite risk to 
life that epilepsy carries, particularly generalized 
uncontrolled seizures, has been erased. Acknow- 
ledgement without overstatement, rather than 
attempts at concealment, is required to place this 
risk in perspective. This would allow the physi- 
cian to take sudden deaths into consideration in 
clinical management, and the patient to make 
more informed decisions when contemplating 
treatment options and when making choices 
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regarding social circumstances. It also allows us, 
perhaps belatedly, to add preservation of life to 
other aims in the treatment of epilepsy. 
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